Albertsons Companies (ACI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Board of directors and corporate governance
Board met ten times and acted five times via written consent during fiscal 2024.
All directors, including Mr. Turner, attended at least 75% of Board and committee meetings in fiscal 2024.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Albertsons Companies
- Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202410 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACIQ1 20259 Jan 2026
- Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACIQ3 20257 Jan 2026
- Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACIQ2 20257 Jan 2026
- Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACIQ4 202419 Dec 2025
- Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACIProxy Filing1 Dec 2025
- Annual meeting to vote on directors, auditor, and pay, with focus on merger, governance, and ESG.ACIProxy Filing1 Dec 2025
- Annual proxy statement outlines voting items and confirms standard shareholder meeting.ACIProxy Filing1 Dec 2025
- Definitive additional proxy materials filed for shareholder voting, with no fee required.ACIProxy Filing1 Dec 2025